Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
[Cannabinoid drugs for neurological diseases: what is behind?].
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Neurorehabilitation for other neurologic disorders.
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.
Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Breastfeeding is associated with lower risk for multiple sclerosis.
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
Cannabinoid pharmacology: the first 66 years.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
Fampridine – Benefit assessment according to § 35a Social Code Book V
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.

Pages